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Abstract
Homeostatic proliferation ensures the longevity of central memory T-cells by inducing cell proliferation in the absence of
cellular differentiation or activation. This process is governed mainly by IL-7. Central memory T-cells can also be stimulated
via engagement of the T-cell receptor, leading to cell proliferation but also activation and differentiation. Using an in vitro
model of HIV-1 latency, we have examined in detail the effects of homeostatic proliferation on latently infected central
memory T cells. We have also used antigenic stimulation via anti-CD3/anti-CD28 antibodies and established a comparison
with a homeostatic proliferation stimulus, to evaluate potential differences in how either treatment affects the dynamics of
latent virus populations. First, we show that homeostatic proliferation, as induced by a combination of IL-2 plus IL-7, leads
to partial reactivation of latent HIV-1 but is unable to reduce the size of the reservoir in vitro. Second, latently infected cells
are able to homeostatically proliferate in the absence of viral reactivation or cell differentiation. These results indicate that
IL-2 plus IL-7 may induce a detrimental effect by favoring the maintenance of the latent HIV-1 reservoir. On the other hand,
antigenic stimulation efficiently reactivated latent HIV-1 in cultured central memory cells and led to depletion of the latently
infected cells via virus-induced cell death.
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Introduction
The existence of latent reservoirs of HIV-infected cells
constitutes a major impediment to viral eradication. HIV-1 latent
reservoirs are small, but extremely long-lived. Latent infection is
associated with undetectable levels of viral gene expression and
appears to be non-cytopathic. However, upon reactivation, latent
viruses enter an active mode of replication in which they are fully
competent for spread and induction of disease [1,2,3]. It is unclear
which physiological stimuli may trigger or prevent viral reactiva-
tion in latently infected cells. Obvious possibilities include
antigenic stimulation, inflammatory conditions, and, perhaps,
certain immunological microenvironments. Regarding potential
therapies, the current thinking in the field is that a combination of
hypothetical drugs that will reactivate latent viruses (‘‘anti-latency’’
drugs), with present-day antiretroviral drugs, will be an effective
approach toward viral eradication [1,4,5]. However, we are
limited by the lack of known drugs that can safely be used to
induce viral reactivation in patients. We are also limited by our
poor understanding of how cellular and viral factors govern the
establishment of latency and the reactivation process.
Memory is a hallmark of the acquired immune system and
results from the clonal expansion and differentiation of antigen-
specific lymphocytes that persist for a lifetime. Memory T cells
result from the activation and differentiation of naı ¨ve T cells and
perform two indispensable and complementary functions, which
are carried out by different cellular subsets [6]. Effector memory T
cells (TEM) migrate to inflamed peripheral tissues and display
immediate effector function. On the other hand, central memory
T cells (TCM) home to areas of secondary lymphoid organs where,
in response to antigenic stimulation, they can vigorously proliferate
and differentiate to TEM. In the case of the CD4+ memory T cells,
the effector subset is further subdivided into several T-helper types,
such as TH1, TH2 and TH17, among others, which are
characterized by the expression of specific chemokine receptors
and the production of specific cytokines like IFNc, IL-4 or IL-17,
respectively [7].
The proliferation of memory T cells can be driven by antigenic
stimulation (antigen-driven proliferation) or by cytokines (homeo-
static proliferation). Through homeostatic proliferation, the
immune system is able to maintain normal T-cell counts, and to
correct for deviations due to expansion or depletion of the memory
cell pool [8,9,10]. Homeostatic proliferation is governed by
extrinsic cellular signals, typically cc-cytokines, in the absence of
antigenic stimulation. For CD4
+ memory T cells, IL-7 is key in
governing homeostasis [8,11,12]. A role for IL-15, another cc-
cytokine, has also been proposed [11].
Previous work by several groups (reviewed in [13,14]) suggested
that in vivo, quiescent memory T-cells constitute a long-lived viral
reservoir, whose decay constant ranges from months to years. A
recent report has provided additional evidence to support the role
of central memory T cells (TCM), along with transitional memory
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Chomont et al. study also proposed that cells in the latent reservoir
may be able to undergo homeostatic proliferation (as evidenced by
the presence of the Ki67 marker), and this in turn would provide a
means for the maintenance or even expansion of the HIV-1 latent
reservoir [15]. While this idea could not be tested in patient cells
due to the low abundance of latent infection, we were able to test
the effect of homeostatic proliferation of latently infected cells in
our cultured TCM model of latency [16]. Using this model, we
confirm the ability of TCM cells to homeostatically proliferate in
response to IL-2 plus IL-7, in a manner that is indistinguishable
between uninfected and latently infected ones. We also demon-
strate that proliferation of infected cells in response to IL-2 plus IL-
7 stimulation is accompanied by inefficient viral reactivation.
Because of the inefficient viral reactivation, many residual latently
infected cells remain which can later be reactivated using antigenic
stimulation.
Results
Antigenic stimulation of latently infected cultured TCM
effectively depletes the latent reservoir whereas
homeostatic proliferation fails to do so
To investigate the effect of homeostatic proliferation and
antigen stimulation signals on the dynamics of a latent infection,
we first established a population of latently infected cultured, non-
polarized (NP) cells, as previously described [16]. NP cells are
considered the in vitro equivalent of in vivo TCM [17,18] and we will
hereinafter refer to them as ‘‘cultured’’ TCM. Peripheral blood
mononuclear cells (PBMC) were obtained from healthy human
donors, and naı ¨ve CD4+ cells were isolated via negative selection
[18]. Purified naı ¨ve CD4
+ T cells were activated (day 0 to day 3)
by incubation with beads coated with aCD3 and aCD28
antibodies in medium containing TGF-b1, aIL-12 and aIL-4
antibodies, and then cultured for 4 additional days with IL-2
(Figure 1A). Cells were then infected with 500 ng of p24 of the
virus, DHIV/X4. DHIV/X4 is an envelope-defective molecular
clone derived from HIV-1NL4-3, which is pseudotyped with the
HIV-1LAI envelope glycoprotein. Because of the env deletion, this
virus is only capable of a single round of infection.
After infection, cells were cultured in medium containing IL-2
for an additional 7 days. Under these conditions, most of the cells
returned to a quiescent state characterized as G0 as evidenced by
low pyronin and 7-AAD staining intensities (Figure S1), where the
vast majority of proviruses exist in a latent state [16]. The
continuous presence of IL-2 in the culture did not interfere with
either the establishment of latency or the return to quiescence of
the cells [16]. IL-2 was, however, required for survival of the cells
in culture (data not shown). At day 14 (first reactivation;
Figure 1A), we tested the ability of IL-7 to induce viral reactivation
in cultured TCM cells. To that end, cells were exposed to normal
medium containing IL-2, IL-7 or a combination of IL-2 plus IL-7
(IL-2+IL-7). As a positive control for virus reactivation, cells were
incubated with beads coated with aCD3/aCD28 antibodies. In a
representative donor shown in Figure 1A, latently infected cells
stimulated with aCD3/aCD28 displayed 43.4% p24Gag
+ cells,
while incubation with IL-2+IL-7 only resulted in 6.3% p24Gag
+
cells. Treatments with IL-2 or IL-7 alone reactivated latent viruses
even less efficiently (1.2 and 3.5%, respectively). When we
performed similar studies with cells from three additional healthy
donors, IL-7 alone failed to reactivate latent HIV-1 in two donors.
However, IL-2+IL-7 treatment reactivated latent HIV-1 in all four
donors with a frequency that was, on average, one tenth of that
obtained with aCD3/aCD28 incubation (Figure 1B). Therefore,
IL-7 treatment reactivated latent viruses in 2 out of 4 donors and,
when used in combination with IL-2, in 4 out of 4 donors; and
always with a lower efficiency than that obtained with antigenic
stimulation. Our results are in agreement with published reports
showing that incubation with IL-7, either alone [19] or in
combination with IL-2 [20] can reactivate latent HIV-1 in resting
CD4+ T cells isolated from infected individuals. IL-7 also
reactivated latent HIV-1 in thymocytes in a SCID-hu mouse
model of HIV latency [21].
To explore the relatively low efficiency of viral reactivation
induced by IL-7 alone or in combination with IL-2 we measured
the levels of expression of the high-affinity alpha chain receptors
for IL-2 or IL-7 (CD25 and CD127, respectively). As shown in
Figure S2A, the frequencies of cultured TCM expressing CD25 and
CD127 were high (81% and 24%, respectively), and similar to
those observed in freshly isolated TCM (66% and 31%,
respectively) although the mean fluorescence intensities (MFI)
were low. For CD25, when cells were stimulated with aCD3/
aCD28, MFI increased by almost two orders of magnitude (Figure
S2B). In addition, a dose-response study indicated that the levels of
IL-7 we utilized in the experiment shown in Figure 1 (50 ng/ml)
and throughout the rest of the study produced near-maximal
response in these cells (Figure S2C). Therefore, the low relative
efficiency of viral reactivation induced by IL-2+IL-7 was also not
due to suboptimal amounts of IL-7.
A minority of cells in the cytokine treatments shown in
Figure 1A reactivated latent viruses as evidenced by intracellular
p24 expression. The remainder of the cells failed to reactivate
latent proviruses and, therefore, we predicted that they remained
latently infected. To prove that residual latent viruses were indeed
present after cytokine stimulation, we cultured these cells in IL-2
for an additional week, and then proceeded to stimulate with
aCD3/aCD28 antibodies (day 24, second reactivation; Figure 1A,
right panels). The latently infected culture that had previously
been reactivated with aCD3/aCD28 antibodies (first reactivation)
and produced 43.4% p24Gag
+ cells, failed to produce additional
p24Gag
+ cells (0.25%) upon the second reactivation (Figure 1A,
aCD3/aCD28 right panel).
The reasons for the lack of p24Gag
+ cells after the second
reactivation with aCD3/aCD28 are as follows. First, aCD3/
aCD28 treatment induces reactivation of virtually all latently
infected cells in the cultured TCM model [16]. Second, cells in
Author Summary
HIV-1 latently infected cells are considered the last barrier
towards viral eradication and cure. However, the low
number of latently infected cells found in patients makes
studies extremely difficult. Here, using a model of primary
CD4 T-cells we study the behavior of latently infected
central memory T cells when undergoing homeostatic
proliferation. Homeostatic proliferation ensures the lon-
gevity of the central memory population, as it does not
involve cellular differentiation. In the context of HIV
infection, IL-7 has been reported to induce viral outgrowth
from latently infected cells in different cellular models.
However, those studies did not examine the relationship
between cell proliferation and viral reactivation. We here
report that the strong effect of IL-7 on the proliferation of
memory cells counteracts this cytokine’s modest ability to
purge latent viruses. Thus, central memory cells are subject
to homeostatic proliferation, a physiological effect that
may contribute to the longevity of the latent reservoir in
HIV-1 infected patients.
Homeostatic Proliferation and HIV-1 Latency
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DHIV is a defective virus, which is unable to spread after the
initial infection. Therefore, new infections are not generated when
latent viruses reactivate. This simplifies the analysis because it rules
out virus spread as a potential confounding factor upon
reactivation. It also obviates the use of anti-retrovirals in the cell
cultures in order to suppress viral spread. To ascertain whether, in
this in vitro system, aCD3/aCD28 stimulation effectively depletes
the latent reservoir, we performed a parallel experiment in which
we also measured integrated HIV-1 DNA by Alu-LTR PCR prior
to the first and the second reactivations. As shown in Figure S3B,
the levels of integrated DNA in DHIV infected cells prior to the
second reactivation decreased to background, undetectable levels,
confirming the absence of residual latently infected cells.
Latently infected cells that had been exposed either to IL-2, IL-
7, or IL-2+IL-7, when later exposed to aCD3/aCD28 antibodies,
produced numerous p24Gag
+ cells (55.1%, 65.5% and 64.5%,
respectively, Figure 1B right panels). Therefore, latently infected
cells that failed to reactivate in the presence of no stimulus (IL-2
alone) or a weak stimulus (IL-7 or IL-2+IL-7) remained as an
inducible reservoir. Similar results were obtained in a total of three
donors (Figure 1C).
Reactivation of latent HIV-1 by IL-2+IL-7 in quiescent TCM
is independent of entry into the cell cycle
Homeostatic proliferation of central memory T cells consists of
entry into the cell division cycle, in the absence of cellular
differentiation [12]. To confirm that IL-7 treatment alone, or in
combination with IL-2, induces homeostatic proliferation, we
determined the division status of the cells via staining for the
nuclear antigen, Ki67. Ki67 is a nuclear marker that is present
during all active phases of the cell cycle (G1,S ,G 2 and mitosis), but
is absent in resting (G0) cells [23]. Ki67 staining was performed in
conjunction with p24Gag staining, in order to evaluate whether
viral reactivation was interdependent with entry into the cell cycle
(Figure 2A). For the donor shown in Figure 2A, IL-2+IL7
incubation induced the strongest proliferation signal compared to
other cytokine treatments or the no-cytokine control. The
proportions of Ki67
+ cells were similar in infected and mock-
infected cultures (Figure 2A). Similar results were obtained in cells
from four donors (Figure 2B). These observations indicate that the
ability of cultured TCM cells to enter cell division upon IL-2+IL-7
stimulation is not affected by the presence of latent infections.
It is important to note that IL-2+IL-7 stimulation induced
latently infected cells to express p24Gag both in the dividing,
Ki67
+ (2.8%), and in the non-dividing, Ki67
2 (4.2%) compart-
ments (Figure 2A). We normalized the above frequencies of
reactivation to the proportions of cells that were Ki67
+ [2.8/
(27.2+2.8)]6100=9.3% or Ki67
2 [4.2/(65.8+4.2)]6100=6.0%.
We performed this analysis for the four donors shown in Figure 2B.
The results showed not statistically significant differences (n=4;
p=0.29; Figure 2C). Thus, we conclude, that entry into the cell
cycle does not influence, positively or negatively, whether a latent
virus will be reactivated by treatment with IL-2+IL-7.
Analysis of the cell surface phenotype of the cytokine-treated
cultures revealed that the majority of the cells maintained the
phenotype of central memory cells, characterized by dual
expression of CCR7 and CD27. Therefore, the IL-7 or IL-2+IL-
7 induced cellular proliferation did not change the differentiation
status of cultured TCM cells, a hallmark of homeostatic
proliferation (Figure S4).
Latently infected, cultured TCM undergo homeostatic
proliferation in the absence of viral reactivation
The above experiments focused on the fraction of cells that
reactivated virus under homeostatic proliferation, but did not
reveal whether residual proviruses that remain latent after IL-7 or
IL-2+IL-7 stimulation may be present within the proliferating
(Ki67
+) or non-proliferating (Ki67
2) populations. Ki67 and
p24Gag co-staining require fixation and permeabilization of the
cells, which precludes further culture and reactivation of cells.
Therefore, to more closely examine the fate of the latently infected
population, we resorted to a different experimental scenario, as
follows. To track cell division, we used Cell Proliferation Dye
eFluor 670 (CPe670), a red-fluorescent dye that is analogous to the
well-known carboxyfluorescein succinimidyl ester (CFSE). The
progressive 2-fold dilution of CPe670 fluorescence within daughter
cells following each cell division is used as an easy and quantitative
means for measuring cell division in individual cells. The use of the
red CPe670 allowed us to use a virus that expresses GFP in place
of nef (DHIV-GFP). The combined use of CPe670 and GFP was
designed to allow us to monitor and sort infected cells, assess cell
division status, and continue to culture the cells thereafter.
We previously showed that GFP expression driven by DHIV-
GFP closely parallels that of p24Gag and that the absence of nef
did not modify the ability of HIV-1 to establish latent infection or
to reactivate in cultured TCM [16]. A latent infection was
established using DHIV-GFP (day 7), and at day 14, cells were
labeled with CPe670; cells were then treated with either IL-2 alone
or IL-2+IL-7. We decided to use the combination of both
cytokines and not IL-7 alone because the combination induced a
stronger and more consistent proliferative effect among different
donors (Figures 2A and 2B) without altering the phenotype of the
cells (Figure S4).
Five days after the above treatment (day 19; Figure 3A), cells
were sorted by flow cytometry in order to (a) remove the GFP
+
fraction; and (b) separate the GFP
2 fraction into CPe670
High
(having undergone no cell divisions) or CPe670
Low (having
undergone one or more cell divisions). As shown in Figure 3B,
only 10.7% of the IL-2-cultured cells underwent cell division,
whereas 31.6% of the cells did so when incubated with IL-2+IL-7.
After sorting, the four cultures shown in Figure 3B (IL-2,
IL-2+IL-7 [unsorted], IL-2+IL-7 [CPe670
High] and IL-2+IL-7
[CPe670
Low]) were placed back in culture and reactivated with
aCD3/aCD28 to reactivate latent viruses; or they were cultured
Figure 1. IL-7 induces partial reactivation of latent HIV-1 in cultured TCM. (A) Mock or DHIV latently infected, cultured TCM were incubated in
the presence of IL-2, IL-7 or a combination of IL-2 and IL-7 (IL-2+IL-7) or costimulated with antibodies to CD3 and CD28 (aCD3/aCD28) and assessed
for intracellular p24Gag by flow cytometry (1st Reactivation). The percentage of p24Gag positive cells is indicated in each panel. After reactivation,
cells were kept in culture for an additional 7-day period in the presence of IL-2. At day 24, cells were incubated in the presence of IL-2 or costimulated
with antibodies to CD3 and CD28 (aCD3/aCD28) and assessed for intracellular p24Gag by flow cytometry (2nd Reactivation). Data is representative of
4 donors for 1
st reactivation and 3 donors for 2
nd reactivation (p.r. post reactivation). (B) Box-plots corresponding to the 4 donors analyzed as in A, left
panels. Horizontal lines indicate median values; statistical significance was assessed by 2-tailed paired-sample t test analysis (P values provided, N.S.
not significant). (C) 3 of these previous donors were analyzed as in A (right panels, 2nd Reactivation), and compared with the first reactivation with
aCD3/aCD28. Horizontal lines indicate median values; statistical significance was assessed by 2-tailed paired-sample t test analysis (P values provided,
N.S. not significant).
doi:10.1371/journal.ppat.1002288.g001
Homeostatic Proliferation and HIV-1 Latency
PLoS Pathogens | www.plospathogens.org 4 October 2011 | Volume 7 | Issue 10 | e1002288in IL-2 for 3 days. Cells were then analyzed for GFP expression.
As shown in Figure 3B (right panels), all four cultures were able to
produce GFP
+ cells after aCD3/aCD28 reactivation. The
frequencies of GFP
+ cells induced by the aCD3/aCD28 treatment
correspond to the frequencies of latency prior to reactivation. The
IL-2+IL-7 stimulated, unsorted culture revealed 24.4% GFP
+ cells
after aCD3/aCD28 reactivation. Cells that underwent no
divisions (CPe670
High) sorted from the previous culture produced
7.03% GFP
+ events, whereas those that had divided at least once
(CPe670
Low) produced 21.7% GFP
+. Therefore, we conclude that
cells that fail to reactivate latent HIV-1 in response to homeostatic
proliferation signals manage to preserve latent infections, and this
occurs whether cells divide or not.
The results from the above analysis was extended to a total of 5
different donors, and the results are summarized in Figure 3C.
The frequencies of latent proviruses present in the dividing versus
the non-dividing cell populations are not statistically significant
(n=5; p=0.36). To directly determine the levels of latently
infected cells in these subsets in a manner that does not relay on
viral reactivation, Alu-LTR PCR was performed in cells from two
donors (white and black bars in Figure 3D) after the cell sorting. As
shown in Figure 3D, the levels of integrated DNA remained
similar in cells treated with IL-2 or IL-2+IL-7; and between cells
that had divided (CPe670
High) versus those that had not
(CPe670
Low). Therefore, we conclude that latently infected cells
can proliferate in response to homeostatic proliferation signals,
allowing for mitotic spread of the latent proviruses within.
Discussion
Previous studies have shown that IL-7 or IL-2+IL-7 stimulation is
able to induce HIV-1 reactivation in latently infected, resting cells
isolated from infected individuals [19,20] and in thymocytes from a
SCID-hu mouse model of HIV-1 latency [21]. However, the above
Figure 2. IL-7 induces cell cycle entry of cultured TCM. (A) Mock or DHIV latently infected, cultured TCM were left in the absence of cytokines
(None) or in the presence of IL-2, IL-7 or a combination of IL-2 and IL-7 (IL-2+IL-7) or costimulated with antibodies to CD3 and CD28 (aCD3/aCD28)
and assessed for intracellular p24Gag and Ki67 expression by flow cytometry. Numbers in boxes indicate percentages. (B) Analysis corresponding to 4
different donors analyzed as shown in panel A; each donor is represented with a different symbol and horizontal lines indicate media values.
Statistical significance was calculated by 2-tailed paired-sample t test analysis (P values provided, N.S. not significant). (C) Analysis of the percentage
of p24Gag
+ cells in each compartment (Ki67
2 or Ki67
+) after IL-2+IL-7 treatment in the four donors analyzed in B. Data was normalized as indicated in
the text. Horizontal lines indicate media values. Statistical significance was calculated by 2-tailed paired-sample t test analysis (N.S. not significant).
doi:10.1371/journal.ppat.1002288.g002
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size of the latent reservoir in TCM. In the present study, we show
that, although homeostatic proliferation signals are able to induce
partial viral reactivation from HIV-1 latency in TCM cells, cell
proliferation may nullify the potential benefits of IL-7 as a natural
‘‘anti-latency’’ treatment. It is noteworthy that while incubation
with IL-2 alone induced very low levels of reactivation in our
system, others have reported significant effects of IL-2 [24]. Two
crucial differences come to mind when trying to reconcile our study
with that of Gondois-Rey et al. [24]. First, Gondois-Rey et al. used
PHA instead of aCD3/aCD28 for T-cell stimulation. Second, our
studies isolate cells with a pure central memory phenotype, whereas
Gondois-Rey et al. did not discriminate between central, transi-
tional and effector memory cells. These discrepancies may underlie
dramatic differences in the responsiveness of various T cell subsets
to IL-2 and should be further examined.
Because HIV-1 latently infected TCM cells do not detectably
express viral antigens, there is no reason to suspect that
Figure 3. Most latently infected cells can proliferate in response to IL-2 plus IL-7 without inducing viral reactivation. (A) Timeline of
the experiment. (B) At day 19, cells treated with IL-2 plus IL-7 (unsorted) were subjected to cell sorting into two populations: CPe670
High (undivided
cells) or CPe670
Low (divided cells). The percentages of CPe670
High and CPe670
Low cells are indicated in the histograms. After sorting, cells were
incubated in the presence of IL-2 or costimulated with antibodies to CD3 and CD28 (aCD3/aCD28) and assessed for GFP expression by flow
cytometry. The three groups of cells treated with IL-2+IL-7 were compared with the same cells treated with IL-2 alone (IL-2). The percentages of GFP
positive cells are indicated in each panel. (C) Box-plots corresponding to the 5 donors analyzed as in B. Horizontal lines indicate median values;
statistical significance was assessed by 2-tailed paired-sample t test analysis (N.S. not significant). (D) Integrated HIV-1 DNA was analyzed by Alu-LTR
PCR in duplicates in two donors from panel C. Results were normalized for each donor relative to the levels of integration in cells treated with IL-2.
Black bars correspond to a donor with 6.5% of GFP positive cells after reactivation with aCD3/aCD28 of cells treated with IL-2. White bars correspond
to a donor with 4.2% of GFP positive cells after reactivation with aCD3/aCD28 of cells treated with IL-2. Mock infected cells retrieved a value below
the threshold of detection of the technique (ND not determined).
doi:10.1371/journal.ppat.1002288.g003
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versus uninfected cells. In fact, our results using cultured TCM
indicate that there is not a statistically significant difference
between latently infected cells and uninfected ones (Figures 3C) in
their abilities to proliferate. We surmise that the normal ability of
latently infected cells to proliferate is an important contributor
toward their long-term maintenance. This result also indicates that
the resting state is not an absolute requirement toward establishing
latency. A clear precedent for this notion is the well known fact
that certain immortalized cell lines can harbor latent viruses
indefinitely, which are capable of being reactivated [25,26].
Therefore, cell division status can be independent of latency, and
we here extended this notion to primary TCM cells.
Using cultured TCM cells, we were also able to model the
dramatic effect of antigenic stimulation on the size of the latent
reservoir in TCM. The results indicate that antigenic stimulation
can deplete the latent reservoir via viral reactivation, whereas
weak stimuli, such as IL-2 or IL-2+IL-7, are unable to do so
(Figure 1).
In this report, we carefully analyze the effect of homeostatic
proliferation and antigen stimulation on HIV-1 latently infected
TCM in vitro. As this reservoir in vivo is extremely long-lived and
impervious to conventional anti-retroviral treatment, analysis of
other factors that may impact the latent reservoir in patients is
extremely compelling. Such factors will likely include a plethora of
immunological mediators, general and specific inflammatory
conditions, and the presence of other infectious agents.
In addition to the documented ability of IL-7 to induce
reactivation of latent HIV-1 in resting cells from patients [19,20],
recombinant IL-7 (rIL-7) has shown efficacy in combating
lymphopenia when administered to HIV-1 patients [27]. These
benefits, combined with the low toxicity observed in the setting of
rIL-7 administration, have prompted several clinical trials with the
goal of eradicating the HIV-1 reservoir with rIL-7 administration.
In the past, potential anti-latency drugs were evaluated for their
ability to induce virus replication in the face of minimal cellular
activation [28,29]. Given the results presented here, we propose
that potential ‘‘anti-latency’’ drugs should also be examined for the
undesired ability to induce cellular proliferation in the presence of
incomplete viral reactivation.
Methods
Reagents
The following reagents were obtained through the AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID: Human rIL-2 from Dr. Maurice Gately, Hoffman-La
Roche Inc. [30]; and Monoclonal Antibody to HIV-1 p24 (AG3.0)
from Dr. Jonathan Allan [31].
Generation of cultured TCM cells and their latent infection
Peripheral blood mononuclear cells were obtained from
Leukopaks from unidentified, healthy donors. Cultured TCM and
latently infected cultured TCM were generated as previously
described [16,18].
Ethics statement
Cells from uninfected blood donors. Human subjects 18 years
and older serve as blood donors. Written informed consent was
obtained from all donors. These studies are covered under the IRB
#392 protocol approved by the University of Utah Institutional
Review Board. The amount of blood drawn varies, depending on
the experiments to be done. This ranges from as little as 50
milliliters (ml) to as much as 500 ml in young, healthy donors.
Reactivation assays
2.5610
5 cells were reactivated with beads coated with aCD3
and aCD28 (1 bead per cell, Dynal/Invitrogen, Carlsbad, CA)
during 3 days in the presence of 30 IU/ml IL-2; with IL-2 alone;
with 50 ng/ml of IL-7 alone or with a combination of IL-2 and IL-
7 (Peprotech, Rocky Hill, NJ) for 5 days.
Flow cytometry
To assess intracellular p24Gag expression, 2.5610
5 cells were
fixed, permeabilized, and stained as previously described [16].
To phenotype the cells, 2.5610
5 cells were stained with surface
marker-specific mAb specific for human: PE-anti-CD25 (Caltag,
Burlingame, CA), FITC-anti-CD127 (eBioscience, San Diego,
CA), PE-anti-CD27 (Caltag, Burlingame, CA) or FITC-anti-
CCR7 (R&D Systems, Minneapolis, MN) followed by flow
cytometric analysis in a BD Facscanto II flow cytometer using
the FACSDiva software (Becton Dickinson, Mountain View, CA)
and analyzed using FlowJo (Tree Star Inc., Ashland, OR). To
analyze the expression of CD25 and CD127 in ex vivo isolated
TCM, memory CD4+ T cells were isolated by MACS microbead-
negative sorting using the memory CD4+ T cell isolation kit
(Miltenyi Biotec, Auburn, CA). After sorting, cells were stained
with FITC-anti-CD127, PE-anti-CD27 and APC-anti-CCR7
(R&D Systems, Minneapolis, MN); or FITC-anti-CD27 (Caltag,
Burlingame, CA), PE-annti-CD25 and APC-anti-CCR7 followed
by flow cytometric analysis as described above.
To analyze the dual expression of Ki67 and p24Gag, 5610
5
cells were fixed, permeabilized and stained for p24Gag as
previously described [16]. After p24Gag staining, cells were
washed with Perm/Wash Buffer (BD Biosciences) and were
incubated with 1/100 dilution of Mouse IgG1,k (MOPC-21,
Sigma, Saint Louis, MO) in 100 ml of Perm/Wash Buffer for
30 min at 4uC to remove excess of secondary antibody. Cells were
then washed with Perm/Wash Buffer and incubated with a 1/20
dilution of anti-Ki67-PE (BD Biosciences) in 100 ml of Perm/Wash
Buffer for 30 min at 4uC. Cells were washed with Perm/Wash
Buffer and samples were analyzed on a FACSCalibur flow
cytometer. Forward versus side scatter profiles were used to define
the live population. In all the experiments, HIV p24Gag negative
staining regions were set with uninfected cells treated in parallel
and Ki67 negative staining regions were set with the correspond-
ing IgG-PE.
To analyze cell division with Cell Proliferation Dye eFluor 670
(eBioscience, San Diego, CA), cells were stained as indicated by
the manufacturer.
To analyze DNA and RNA content, samples were stained with
7-aminoactinomycin D (7-AAD) and pyronin Y (PY) as previously
described [32].
Integration analysis
Genomic DNA was isolated with DNeasy Tissue Kit (QIAGEN,
Valencia, CA). Genomic DNA (250 ng) was subjected to
quantitative Alu-LTR polymerase chain reaction (PCR) for
integrated proviruses as previously described [33,34].
Supporting Information
Figure S1 (A) Analysis of DNA (7-AAD) and RNA (PY) content
in cultured TCM. Cells were stained with 7-AAD and PY at the
time of reactivation (Day 14) in the presence of IL-2 (IL-2) or in
the absence of IL-2 for 4 days (None). Numbers in boxes indicate
percentages. The different phases of the cell cycle are indicated in
the right panel.
(TIF)
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CD127 (IL-7Ra) in cultured TCM or ex vivo TCM. The percentage
of positive cells is indicated. (B) Analysis of expression of CD25
(IL-2Ra) in cultured TCM (Black-filled histogram) or cultured TCM
activated with aCD3/aCD28 antibodies for 72 hours (Dark-filled
histogram). IgG isotype control is the light grey-filled histogram.
(C) Dose-response curve of viral reactivation induce by a
combination of IL-2 at 30 IU/ml and increasing concentrations
of IL-7. The percentage of p24Gag positive cells is indicated in the
Y-axis.
(TIF)
Figure S3 (A) Levels of p24Gag positive cells after reactivation
with aCD3/aCD28 antibodies in the 1
st and 2
nd reactivation for a
representative donor. (B) Integrated HIV-1 DNA was analyzed by
Alu-LTR PCR in triplicates in the donor from panel A prior to
reactivation. Results were normalized relative to the levels of
integration in DHIV infected cells before the first reactivation.
Mock infected cells and DHIV infected cells prior to second
reactivation retrieved a value below the threshold of detection of
the technique (C) Amplification curves form the same samples
used for B.
(TIF)
Figure S4 Expression of CCR7 and CD27 in mock or DHIV-
latently infected cultured TCM cells at day 14 (Day 7 p.i.). The
expression was also monitored 5 days after incubation of the cells
in the absence of cytokines (none) or with IL-2, IL-7 or a
combination of IL-2 and IL-7 (IL-2+IL-7).
(TIF)
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